Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development
Open Access
- 8 March 2018
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 45 (3) , 457-467
Abstract
Cardiotoxicity is among the top drug safety concerns, and is of specific interest in tuberculosis, where this is a known or potential adverse event of current and emerging treatment regimens. As there is a need for a tool, beyond the QT interval, to quantify cardiotoxicity early in drug development, an empirical decision tree based classifier was developed to predict the risk of Torsades de pointes (TdP). The cardiac risk algorithm was developed using pseudo-electrocardiogram (ECG) outputs derived from cardiac myocyte electromechanical model simulations of increasing concentrations of 96 reference compounds which represented a range of clinical TdP risk. The algorithm correctly classified 89% of reference compounds with moderate sensitivity and high specificity (71 and 96%, respectively) as well as 10 out of 12 external validation compounds and the anti-TB drugs moxifloxacin and bedaquiline. The cardiac risk algorithm is suitable to help inform early drug development decisions in TB and will evolve with the addition of emerging data.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1031105)
This publication has 37 references indexed in Scilit:
- Circadian Models of Serum Potassium, Sodium, and Calcium Concentrations in Healthy Individuals and Their Application to Cardiac Electrophysiology Simulations at Individual LevelComputational and Mathematical Methods in Medicine, 2013
- A new biomarker – index of Cardiac Electrophysiological Balance (iCEB) – plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs)Journal of Pharmacological and Toxicological Methods, 2013
- Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case studyTheoretical Biology and Medical Modelling, 2013
- Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pigJournal of Pharmacological and Toxicological Methods, 2012
- Moxifloxacin SafetyDrugs in R&D, 2012
- Inter-individual Variability in the Pre-clinical Drug Cardiotoxic Safety Assessment—Analysis of the Age–Cardiomyocytes Electric Capacitance DependenceJournal of Cardiovascular Translational Research, 2012
- Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental ValidationPLOS Computational Biology, 2011
- Principles of Safety PharmacologyBritish Journal of Pharmacology, 2008
- A model for human ventricular tissueAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal AgentJournal of Cardiovascular Pharmacology and Therapeutics, 2004